Adiponectin and Chronic Kidney Disease

Journal of Renal Nutrition

Volumn 17, Issue 1, 2007, Pages 9-12

  Guebre Egziabher, Fitsum ^a,b   Drai, Jocelyne ^c   Fouque, Denis ^a,b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN;

ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; HUMAN; INFLAMMATION; KIDNEY DISEASE; METABOLIC SYNDROME X; METABOLISM; PHYSIOLOGY;

ADIPONECTIN; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; HUMANS; INFLAMMATION; KIDNEY DISEASES; METABOLIC SYNDROME X;

EID: 33845724572     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2006.10.003     Document Type: Article

References (31)

1. Scherer P.E., Williams S., Fogliano M., Baldini G., and Lodish H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270 (1995) 26746-26749
2. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999) 79-83
3. Weyer C., Funahashi T., Tanaka S., et al. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86 (2001) 1930-1935
4. Ouchi N., Kihara S., Arita Y., et al. Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 100 (1999) 2473-2476
5. Maeda N., Shimomura I., Kishida K., et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8 (2002) 731-737
6. Kubota N., Terauchi Y., Yamauchi T., et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277 (2002) 25863-25866
7. Yamauchi T., Kamon J., Waki H., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7 (2001) 941-946
8. Zoccali C., Mallamaci F., Tripepi G., et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 13 (2002) 134-141
9. Guebre-Egziabher F., Bernhard J., Funahashi T., Hadj-Aissa A., and Fouque D. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. Nephrol Dial Transplant 20 (2005) 129-134
10. Zoccali C., Mallamaci F., Panuccio V., et al. Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors. Kidney Int 63 (2003) S84-S102
11. Fruebis J., Tsao T.S., Javorschi S., et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 98 (2001) 2005-2010
12. Nawrocki A., Rajala M., Tomas E., et al. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 281 (2001) 2654-2660
13. Ryan A.S., Berman D.M., Nicklas B.J., et al. Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care 26 (2003) 2383-2388
14. Yokota T., Meka C.S., Medina K.L., et al. Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins. J Clin Invest 109 (2002) 1303-1310
15. Hotta K., Funahashi T., Arita Y., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20 (2000) 1595-1599
16. Ouchi N., Kihara S., Arita Y., et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103 (2001) 1057-1063
17. Kern P.A., DiGregorio G.B., Lu T., Rassouli N., and Ranganathan G. Adiponectin expression from human adipose tissue: Relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 52 (2003) 1779-1785
18. Bruun J., Lihn A.S., Verdich C., et al. Regulation of adiponectin by adipose tissue-derived cytokines: In vivo and in vitro investigations in humans. Am J Physiol 285 (2003) E527-E533
19. Miyazaki Y., Mahankali A., Wajcberg E., Bajaj M., Mandarino L., and DeFronzo R. Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 89 (2004) 4312-4319
20. Yilmaz M., Sonmez A., Caglar K., et al. Peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist increases plasma adiponectin levels in type 2 diabetic patients with proteinuria. Endocrine 25 (2004) 207-214
21. Furuhashi M., Ura N., Higashiura K., et al. Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 42 (2003) 76-81
22. Koh K.K., Quon M.J., Han S.H., et al. Vascular and metabolic effects of combined therapy with ramipril and simvastatin in patients with type 2 diabetes. Hypertension 45 (2005) 1088-1093
23. Yang W.S., Lee W.J., Funahashi T., et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86 (2001) 3815-3819
24. Hulver M.W., Zheng D., Tanner C.J., et al. Adiponectin is not altered with exercise training despite enhanced insulin action. Am J Physiol Endocrinol Metab 283 (2002) E861-E865
25. Matsubara M., Maruoka S., and Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol 147 (2002) 173-180
26. Haque W.A., Shimomura I., Matsuzawa Y., and Garg A. Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab 87 (2002) 2395
27. Saraheimo M., Forsblom C., Fagerudd J., et al. Serum adiponectin is increased in type 1 diabetic patients with nephropathy. Diabetes Care 28 (2005) 1410-1414
28. Marchlewska A., Stenvinkel P., Lindholm B., et al. Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease. Kidney Int 66 (2004) 46-50
29. Tentolouris N., Doulgerakis D., Moyssakis I., et al. Plasma adiponectin concentrations in patients with chronic renal failure: Relationship with metabolic risk factors and ischemic heart disease. Horm Metab Res 36 (2004) 721-727
30. Huang J.W., Yen C.J., Chiang H.W., Hung K.Y., Tsai T.J., and Wu K.D. Adiponectin in peritoneal dialysis patients: A comparison with hemodialysis patients and subjects with normal renal function. Am J Kidney Dis 43 (2004) 1047-1055
31. Furuya R., Odamaki M., Kumagai H., and Hishida A. Beneficial effects of icodextrin on plasma level of adipocytokines in peritoneal dialysis patients. Nephrol Dial Transplant 21 (2006) 494-498